Engineered adeno-associated virus 3 vector with reduced reactivity to serum antibodies

Abstract The natural serotypes of adeno-associated virus (AAV) or their variants, such as AAV8 and AAV5, are commonly used as vectors in the clinical programs for liver-targeted gene therapy. While AAV8 vectors are not highly efficient at targeting primary human hepatocytes, AAV3 vectors have recent...

Full description

Saved in:
Bibliographic Details
Main Authors: Mika Ito, Naomi Takino, Takamasa Nomura, Akihiko Kan, Shin-ichi Muramatsu
Format: article
Language:EN
Published: Nature Portfolio 2021
Subjects:
R
Q
Online Access:https://doaj.org/article/21dbdb3102a64787821dc94a450f9501
Tags: Add Tag
No Tags, Be the first to tag this record!